Clinical Trials

  • Study of Learning Mindfulness Meditation to Improve Symptoms in Patients with Long COVID

    Principal Investigator:

    Deborah A Theodore, MD
    This is a study for people with symptoms of long COVID. We are looking for people over the age of 18 who are interested in participating in a study to understand whether a mindfulness meditation intervention can help improve symptoms of long COVID. Study participation lasts 6 months and is fully remote.

  • Study of Vesatolimod (VES), GS-5423, and GS-2872 in PWH (People with HIV)

    Principal Investigator:

    Magdalena E Sobieszczyk, MD, MPH
    The main purpose of this study is to look at whether experimental study drugs are safe, whether your body can handle the effects, and whether these study drugs improve the body's response to human immunodeficiency virus (HIV) in people with HIV (PWH) who started antiretroviral therapy (ART) early after getting HIV-1. The study treatments include: a treatment vaccine (not a preventative vaccine), a drug called vesatolimod (VES), and two broadly neutralizing antibodies (bNAbs; antibodies are natural proteins that the body makes in response to an infection), called GS-5423 and GS-2872. None of...

Pages

Back to top